Should Eligibility for Bariatric Surgery Be Expanded?

Gastroenterology

Volumn 134, Issue 1, 2008, Pages 15-

  Ahima, Rexford S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

SIBUTRAMINE; TETRAHYDROLIPSTATIN;

BARIATRIC SURGERY; BODY MASS; COST BENEFIT ANALYSIS; DISEASE PREDISPOSITION; EDITORIAL; OBESITY; POSTGASTRECTOMY SYNDROME; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SATIETY; STOMACH SURGERY; SURGICAL MORTALITY;

EID: 37349079472     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.11.022     Document Type: Editorial

References (6)

1. Kral J.G., and Naslund E. Surgical treatment of obesity. Nat Clin Pract Endocrinol Metab 3 (2007) 574-583
2. Collazo-Clavell M.L., Clark M.M., McAlpine D.E., et al. Assessment and preparation of patients for bariatric surgery. Mayo Clin Proc 81 10 Suppl (2006) S11-S17
3. Maggard M.A., Shugarman L.R., Suttorp M., et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med 142 (2005) 547-559
4. Sjöström L., Narbro K., Sjostrom C.D., et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357 (2007) 741-752
5. Adams T.D., Gress R.E., Smith S.C., et al. Long-term mortality after gastric bypass surgery. N Engl J Med 357 (2007) 753-761
6. Service G.J., Thompson G.B., Service F.J., et al. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med 353 (2005) 249-254